NasdaqGS - Nasdaq Real Time Price USD

Collegium Pharmaceutical, Inc. (COLL)

29.23
-0.08
(-0.27%)
At close: June 3 at 4:00:02 PM EDT
29.23
0.00
(0.00%)
After hours: June 3 at 4:40:39 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
664,283
631,449
566,767
463,933
276,868
Cost of Revenue
281,071
254,105
240,598
254,445
126,251
Gross Profit
383,212
377,344
326,169
209,488
150,617
Operating Expense
244,804
210,363
159,208
176,169
128,411
Operating Income
138,408
166,981
166,961
33,319
22,206
Net Non Operating Interest Income Expense
-65,711
-59,998
-67,724
-62,166
-21,002
Other Income Expense
--
-8,415
-23,504
--
-4,578
Pretax Income
65,068
98,568
75,733
-28,847
-3,374
Tax Provision
21,174
29,378
27,578
-3,845
-74,891
Net Income Common Stockholders
43,894
69,190
48,155
-25,002
71,517
Average Dilution Earnings
4,241
5,863
5,889
0
4,675
Diluted NI Available to Com Stockholders
48,135
75,053
54,044
-25,002
76,192
Basic EPS
1.36
2.14
1.43
-0.74
2.05
Diluted EPS
1.22
1.86
1.29
-0.74
1.86
Basic Average Shares
32,140.64
32,273.85
33,741.21
33,829.50
34,936.82
Diluted Average Shares
38,274.60
40,424.18
41,788.13
33,829.50
41,045.81
Total Operating Income as Reported
142,108
169,895
166,961
33,319
17,628
Total Expenses
525,875
464,468
399,806
430,614
254,662
Net Income from Continuing & Discontinued Operation
43,894
69,190
48,155
-25,002
71,517
Normalized Income
49,040.42
75,097.33
63,103.54
-25,002
74,858.94
Interest Income
11,714
13,976
15,615
1,047
12
Interest Expense
77,425
73,974
83,339
63,213
21,014
Net Interest Income
-65,711
-59,998
-67,724
-62,166
-21,002
EBIT
142,493
172,542
159,072
34,366
17,640
EBITDA
332,783
341,702
308,328
173,305
86,557
Reconciled Cost of Revenue
281,071
254,105
240,598
254,445
126,251
Reconciled Depreciation
190,290
169,160
149,256
138,939
68,917
Net Income from Continuing Operation Net Minority Interest
43,894
69,190
48,155
-25,002
71,517
Total Unusual Items Excluding Goodwill
-7,629
-8,415
-23,504
0
-4,578
Total Unusual Items
-7,629
-8,415
-23,504
0
-4,578
Normalized EBITDA
340,412
350,117
331,832
173,305
91,135
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-2,482.58
-2,507.67
-8,555.46
0
-1,236.06
12/31/2021 - 5/7/2015

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

PCRX Pacira BioSciences, Inc.
26.40
+0.61%
 
ANIK Anika Therapeutics, Inc.
11.59
+1.22%
 
SUPN Supernus Pharmaceuticals, Inc.
32.23
+1.00%
 
PBH Prestige Consumer Healthcare Inc.
84.87
-0.73%
 
ANIP ANI Pharmaceuticals, Inc.
61.66
-0.40%
 
MPH.V Medicure Inc.
1.0600
0.00%
 
DVAX Dynavax Technologies Corporation
10.01
+1.73%
 
IRWD Ironwood Pharmaceuticals, Inc.
0.6099
-1.95%
 
AMPH Amphastar Pharmaceuticals, Inc.
26.01
+2.48%
 
DERM Journey Medical Corporation
7.20
-7.81%